Furthermore, METTL3 promotes the temozolomide (TMZ) resistance of glioma cells by increasing DNA repair genes O6-methylguanine-DNA methyltransferase (MGMT) and alkylpurine–DNA–N-glycosylase (ANPG) [82]. The gene discussed is METTL3; the disease is central nervous system cancer.